Erythropoietin-induced deep vein thrombosis in myelodysplastic syndrome.
We report a rare case of deep vein thrombosis (DVT) secondary to erythropoietin (EPO) in an 89-year-old patient with myelodysplastic syndrome (MDS). The incidence of EPO-induced thrombotic episode increases with an absolute increase of hemoglobin (Hb) beyond >12 gm/dL or rate of increase of Hb level >1 gm/dL every 2 weeks.
Niazy
M N
MN
Department of Medicine, Al-Sabah Hospital, Ministry of Health, Kuwait.
Neyyarapally
T I
TI
Chattopadhyay
A
A
D000369:Aged, 80 and over; D004921:Erythropoietin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000503:physiopathology*; D020246:Venous Thrombosis / Q000139:chemically induced*
D004921:Erythropoietin